3685932
doi
10.5281/zenodo.3685932
oai:zenodo.org:3685932
user-eu
Adrian Sanz-Moreno
INFRAFRONTIER
Patricia da Silva-Buttkus
INFRAFRONTIER
Serena Battaglia
ECRIN-ERIC
CORBEL Assessment of animal model phenotypes against outcome measures
Nicola Harman
University of Liverpool
info:eu-repo/semantics/openAccess
Creative Commons Attribution 4.0 International
https://creativecommons.org/licenses/by/4.0/legalcode
Animal models
CORBEL
Mouse phenotyping
Clinical outcome measures
<p>Animal models play a crucial role in understanding the mechanisms of diseases and symptoms, and to test the efficacy and safety of treatments before conducting clinical trials. Selecting human diseases and developing core sets of clinical outcome measures as well as complementary sets of mouse phenotyping measures will contribute to narrow the gap between animal models and human trials.</p>
<p>The overall objective of the CORBEL task 3.2 is to promote convergence between outcome measures used for clinical trials in humans and phenotyping techniques used for testing treatments in animal models.</p>
Zenodo
2020-02-24
info:eu-repo/semantics/report
3685931
user-eu
award_title=Coordinated Research Infrastructures Building Enduring Life-science services; award_number=654248; award_identifiers_scheme=url; award_identifiers_identifier=https://cordis.europa.eu/projects/654248; funder_id=00k4n6c32; funder_name=European Commission;
1582615258.899329
1278379
md5:794c5d0bccce561a11a5542fb4532683
https://zenodo.org/records/3685932/files/CORBEL_D3.6_Assessment of animal model phenotypes_February-2020.pdf
public
10.5281/zenodo.3685931
isVersionOf
doi